Latest News about U/S/ Food and Drug Administration
Recent news which mentions U/S/ Food and Drug Administration
51.2 Million Measles Cases, 159,200 Deaths: New Study Warns Of Surge In Preventable Diseases Amid Growing Vaccine Skepticism
June 02, 2025
From Benzinga
From Benzinga
From Benzinga
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
October 16, 2023
From Benzinga
Cannabis Research Company Submits FDA Responses For Gel Capsule Approval
September 20, 2023
From Benzinga
EXCLUSIVE: Curaleaf Chairman Predicts DEA's Future Steps On Cannabis Rescheduling
September 05, 2023
From Benzinga
Ripple Effect: How Marijuana Legalization Impacts Global Drug Cartels, Senators' Letter Reveals
August 24, 2023
From Benzinga
From Benzinga
From Benzinga
Why Changing Marijuana's DEA Categorization Could Be 'The Most Consequential Action Out Of DC'
July 21, 2023
Tickers
FFNTF
From Benzinga
Healthcare Advocates United: A Push For Congress To Recognize CBD As Dietary Supplements
July 20, 2023
Tickers
DRUG
From Benzinga
'War on Vapes' Intensifies: FDA Seizes Disposable Vapes, NYC Files Lawsuit, UK Calls For Ban On Single-Use Vapes
July 18, 2023
From Benzinga
From Benzinga
Biden Cites Federal Cannabis Pardons And Possible Policy Reforms In His Juneteenth Proclamation
June 20, 2023
From Benzinga
Federal Cannabis Scheduling Decision Expected 'This Year,' Says Biden's Health Secretary
June 15, 2023
From Benzinga
Rhode Island Advances Psilocybin Reform With Bill To Legalize Therapeutic Access And Cultivation
June 06, 2023
From Benzinga
From Benzinga
From Benzinga
GOP Rep. Seeks Protection For Vets Who Use Medical Marijuana: They Shouldn't Lose Their Benefits
January 18, 2023
From Benzinga
From Benzinga
Jazz Pharmaceuticals Files Patent Infringement Against Generic Drugmakers In New Jersey's District Court
January 05, 2023
From Benzinga
Bipartisan Cannabis Research Bill Could Cause 'Dire Unintended Consequences' For Industry, Reform Groups Say
October 04, 2022
From Benzinga
Bipartisan Lawmakers Call Out FDA's 'Inadequate' Response To Hemp And CBD Regulations
September 15, 2022
From Benzinga
The U.S. Court Of Appeals Says No To Removing Marijuana From Schedule 1— Says That's Up To Congress
September 14, 2022
From Benzinga
From Benzinga
From Benzinga
Concern About Marijuana Copycat Products Resembling Common Food Brands: State Attorneys General Call On Action To Congress
June 22, 2022
From Benzinga
Freshpet Recalls Dog Food Sold At Target And Walmart Over Possible Salmonella Contamination
June 22, 2022
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.